Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-2015 Apply Investor Resources Results for 2023-2024 USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA 20th Sep 2023 Issuance of duplicate share certificates 15th Sep 2023 Issuance of duplicate share certificates 13th Sep 2023 Allotment of 7,188 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 11th Sep 2023 Press Release - Cipla Medpro South Africa (Pty) Ltd, wholly owned subsidiary of the Company in South Africa to acquire Actor Pharma (Pty) Ltd., South Africa 04th Sep 2023 Investment in Actor Pharma (Pty) Ltd., South Africa 04th Sep 2023 Public Notice - Transfer of Equity Shares to IEPF – 2023 19th Aug 2023 Allotment of 47,205 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 17th Aug 2023 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 16th Aug 2023 Disclosure of material continuing events under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) 14th Aug 2023 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
